Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B1 | P14061 | 3/20 | 0.54 |
| ▸ | HSD17B2 | P37059 | 3/20 | 0.54 |
| ▸ | TRIM24 | O15164 | 1/20 | 0.50 |
| ▸ | TRIM33 | Q9UPN9 | 1/20 | 0.50 |
| ▸ | CA12 | O43570 | 1/20 | 0.49 |
| ▸ | CA1 | P00915 | 1/20 | 0.49 |
| ▸ | CA2 | P00918 | 1/20 | 0.49 |
| ▸ | CA9 | Q16790 | 1/20 | 0.49 |
| ▸ | KIF11 | P52732 | 1/20 | 0.46 |
| ▸ | ERN1 | O75460 | 6/20 | 0.45 |
| ▸ | P4HB | P07237 | 3/20 | 0.44 |
| ▸ | AR | P10275 | 2/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.42 |
| ▸ | RAB9A | P51151 | 1/20 | 0.42 |
| ▸ | APP | P05067 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30679638 | 0.83 | KIF11 (0.55) | TRIM24TRIM33CA12CA1CA2 | |
| SCHEMBL856316 | 0.81 | KDM4E (0.57) | HSD17B1HSD17B2TRIM24TRIM33KIF11 | |
| SCHEMBL29452390 | 0.81 | KDM4E (0.57) | HSD17B1HSD17B2TRIM24TRIM33KIF11 | |
| SCHEMBL30861658 | 0.81 | TRIM24 (0.46) | TRIM24TRIM33CA12CA1CA2 | |
| SCHEMBL3831122 | 0.81 | TRIM24 (0.46) | TRIM24TRIM33CA12CA1CA2 | |
| SCHEMBL6618043 | 0.80 | TRIM24 (0.46) | HSD17B1HSD17B2TRIM24TRIM33CA12 | |
| SCHEMBL26704175 | 0.79 | KIF11 (0.73) | TRIM24TRIM33CA12CA1CA2 | |
| SCHEMBL29485676 | 0.79 | HSD17B1 (0.65) | HSD17B1HSD17B2KIF11ARAPP | |
| SCHEMBL1938893 | 0.79 | HSD17B1 (0.65) | HSD17B1HSD17B2KIF11ARAPP | |
| SCHEMBL6619511 | 0.79 | HSD17B1 (0.59) | HSD17B1HSD17B2TRIM24TRIM33CA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150072969-A1 | PHENYL ALKANOIC ACID DERIVATIVES AS GPR AGONISTS | Piramal Enterprises Limited (IN) | 2015-03-12 | — | — | US | disclosed |
| CN-104144920-A | PHENYL ALKANOIC ACID DERIVATIVES AS GPR AGONISTS | PIRAMAL ENTPR LTD | 2014-11-12 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150072969-A1 | PHENYL ALKANOIC ACID DERIVATIVES AS GPR AGONISTS | GPR55, GPR65, GPR35 | HSD17B1 659/4885HSD17B2 1366/4885TRIM24 2476/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.